https://www.cellphire.com https://www.cellphire.com/clinical-trials-thrombosomes https://www.cellphire.com/search https://www.cellphire.com/clinical-trials https://www.cellphire.com/clinical-trial-faq https://www.cellphire.com/our-science https://www.cellphire.com/our-science-therapeutic-areas https://www.cellphire.com/our-science-why-platelets https://www.cellphire.com/our-science-publications https://www.cellphire.com/careers https://www.cellphire.com/about-us https://www.cellphire.com/leadership-bios https://www.cellphire.com/expanded-access https://www.cellphire.com/pipeline https://www.cellphire.com/thrombosomes-a-platelet-based-freeze-dried-hemostatic https://www.cellphire.com/cryopreserved-platelets-cpp https://www.cellphire.com/cellphire-com-privacy-statement https://www.cellphire.com/terms-of-use https://www.cellphire.com/news https://www.cellphire.com/lottie-test https://www.cellphire.com/clinical-trials-cryopreserved-platelets https://www.cellphire.com/our-science-veterinary-one-health https://www.cellphire.com/contact-us https://www.cellphire.com/our-science-technology https://www.cellphire.com/pipeline-copy https://www.cellphire.com/pipeline-copy-2 https://www.cellphire.com/news/bodevet-chief-technical-officer-to-present-at-iveccs-2017 https://www.cellphire.com/news/bodevet-stableplate-rx-r-launching-in-september-at-iveccs-2017 https://www.cellphire.com/news/cellphire-announces-exercise-by-barda-of-option-3-of-contract-to-develop-platelet-based-hemostatic https://www.cellphire.com/news/cellphire-announces-orphan-drug-designation-of-thrombosomes-r-for-treatment-of-acute-radiation-syndrome https://www.cellphire.com/news/cellphire-announces-the-addition-of-dr-damien-bates-as-cmo https://www.cellphire.com/news/cellphire-awarded-29-25-million-u-s-army-cryopreserved-platelet-development-contract https://www.cellphire.com/news/cellphire-awarded-grant-to-develop-elephant-endotheliotropic-herpesvirus-eehv-freeze-platelet-treatment https://www.cellphire.com/news/cellphire-awarded-subaward-for-darpa-biostasis-program https://www.cellphire.com/news/cellphire-begins-phase-2-trial-of-thrombosomes-r-in-bleeding-thrombocytopenic-patients https://www.cellphire.com/news/cellphire-closes-1-3-million-funding-round https://www.cellphire.com/news/cellphire-closes-15-million-series-a-funding-round-led-by-simcah-management https://www.cellphire.com/news/cellphire-closes-3-000-000-funding-round https://www.cellphire.com/news/cellphire-completes-enrollment-of-phase-1-clinical-trial-of-thrombosomes-r https://www.cellphire.com/news/cellphire-inc-announces-rebrand-to-cellphire-therapeutics-inc https://www.cellphire.com/news/cellphire-investors-receive-50-maryland-biotechnology-investment-incentive-tax-credit https://www.cellphire.com/news/cellphire-investors-receive-maryland-biotechnology-investment-incentive-tax-credit https://www.cellphire.com/news/cellphire-president-g-michael-fitzpatrick-awarded-armed-services-program-lifetime-achievement-award https://www.cellphire.com/news/cellphire-reaches-ia-in-phase-2-3-cryptics-clinical-study https://www.cellphire.com/news/cellphire-subsidiary-bodevet-inc-awarded-1-7-million-u-s-army-contract https://www.cellphire.com/news/cellphire-therapeutics-announces-cryptics-independent-data-monitoring-committee-idmc https://www.cellphire.com/news/cellphire-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-thrombosomes-in-bleeding-thrombocytopenic-patients https://www.cellphire.com/news/cellphire-therapeutics-announces-the-addition-of-dr-ed-coles-to-its-program-management-and-executive-leadership-teams https://www.cellphire.com/news/cellphire-therapeutics-appoints-pamela-b-conley-to-its-board-of-directors https://www.cellphire.com/news/cellphire-therapeutics-appoints-roy-a-beveridge-m-d-to-scientific-advisory-board https://www.cellphire.com/news/cellphire-therapeutics-clph511-fasttrack-designation-granted https://www.cellphire.com/news/cellphire-therapeutics-conducted-cpp-investigator-meeting https://www.cellphire.com/news/cellphire-therapeutics-expands-core-technology-patents https://www.cellphire.com/news/cellphire-therapeutics-forms-strategic-partnership-with-vitalant https://www.cellphire.com/news/cellphire-therapeutics-highlights-new-preclinical-data-demonstrating-vascular-repair-and-neuroprotective-effects-of-platelet-derived-biologic-in-traumatic-brain-injury https://www.cellphire.com/news/cellphire-therapeutics-issued-new-core-technology-patent https://www.cellphire.com/news/cellphire-therapeutics-issued-new-core-technology-patent-antiplatelet-reversal-agent https://www.cellphire.com/news/cellphire-therapeutics-issued-new-core-technology-patent-for-use-of-stabilized-platelet-loaded-with-anti-cancer-agents https://www.cellphire.com/news/cellphire-therapeutics-names-angie-howerton-as-vice-president-of-finance-controller-and-treasurer https://www.cellphire.com/news/cellphire-therapeutics-names-anya-derbij-md-as-vice-president-of-clinical-operations https://www.cellphire.com/news/cellphire-therapeutics-names-michael-gaffney-as-companys-new-ceo https://www.cellphire.com/news/cellphire-therapeutics-names-w-allan-alexander-md-as-chief-medical-officer https://www.cellphire.com/news/cellphire-therapeutics-nominated-for-emerging-life-science-company-of-the-year https://www.cellphire.com/news/cellphire-therapeutics-published-in-jcva https://www.cellphire.com/news/cellphire-therapeutics-the-use-of-stabilized-platelets-for-drug-delivery https://www.cellphire.com/news/cellphire-therapeutics-treats-first-patient-in-phase-2-3 https://www.cellphire.com/news/cellphire-therapeutics-welcomes-randall-stanicky-to-its-board-of-directors https://www.cellphire.com/news/cellphire-wins-montgomery-county-chamber-of-commerce-award-verl-zanders-emerging-business-of-the-year https://www.cellphire.com/news/completion-of-phase-2-clinical-trial-indenmark https://www.cellphire.com/news/dr-anne-hale-dvm-joins-bodevet-as-chief-technical-officer https://www.cellphire.com/news/dr-david-hirsh-joins-cellphire-inc-board-of-directors https://www.cellphire.com/news/dr-heather-f-pidcoke-joins-cellphire-inc-as-chief-medical-officer https://www.cellphire.com/news/first-patient-phase2 https://www.cellphire.com/news/in-memory-of-dr-arthur-bode https://www.cellphire.com/news/issued-new-core-technology-patent https://www.cellphire.com/news/john-b-holcomb-m-d-f-a-c-s-joins-cellphire-as-medical-consultant https://www.cellphire.com/news/keith-a-moskowitz-joins-cellphire-as-vice-president-for-discovery https://www.cellphire.com/news/maryland-venture-fund-provides-1-000-000-investment-to-cellphire https://www.cellphire.com/news/rafael-jorda-joins-cellphire-inc-as-vice-president-of-r-d https://www.cellphire.com/news/rodman-w-moorhead-iii-joins-cellphire-inc-board-of-directors https://www.cellphire.com/news/transfusion-news-thrombosomes-lyophilized-platelets-appear-safe-in-phase-1-trial https://www.cellphire.com/news/umd-program-approves-15-technology-product-development-projects-teaming-maryland-companies-with-system-faculty